APPLIED BIOCODE CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.9 TWD | -0.75% |
|
-0.50% | -21.34% |
| 04-15 | Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only | CI |
| 03-21 | Applied BioCode Announces CEO Changes | CI |
Chart calendar Applied BioCode Corporation
b03f8.BJvUkp9Kx10JsRWNCN1VOOT6w-WQjb9H7pVg6o1v8B4.acztwuoLqi9L5zjBZ7AZeqG9sKf94toDqewPhdcIiCpdrO3wzBqCDXHmTA~80da50473e3b929835eed77f5540b317
Upcoming events on Applied BioCode Corporation
Past events on Applied BioCode Corporation
| 08/05/2024 | Q1 2024 Earnings Release (Projected) |
| 10/04/2024 07:38 | March 2024 Sales and Revenue Release |
| 14/03/2024 08:25 | Q4 2023 Earnings Release |
| 08/03/2024 08:16 | February 2024 Sales and Revenue Release |
| 07/02/2024 05:24 | January 2024 Sales and Revenue Release |
| 12/11/2023 | Q3 2023 Earnings Release |
| 09/11/2023 | October 2023 Sales and Revenue Release |
| 05/10/2023 | September 2023 Sales and Revenue Release |
| 08/09/2023 07:06 | August 2023 Sales and Revenue Release |
| 28/08/2023 08:54 | Q2 2023 Earnings Release |
| 10/08/2023 06:56 | July 2023 Sales and Revenue Release |
| 22/07/2023 | AACC Scientific Meeting |
| 10/07/2023 07:02 | June 2023 Sales and Revenue Release |
| 15/06/2023 | ASM Microbe Conference |
| 12/06/2023 03:00 | Annual General Meeting |
| 09/06/2023 06:56 | May 2023 Sales and Revenue Release |
| 12/05/2023 07:35 | Q1 2023 Earnings Release |
| 10/05/2023 06:49 | April 2023 Sales and Revenue Release |
| 10/04/2023 07:18 | March 2023 Sales and Revenue Release |
| 21/03/2023 08:49 | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 299 299 0.01% | 320 291 9.95% | 390 392 -0.43% | 0,00 | 430 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million TWD | Released Forecast Spread | -134 -107 -24.78% | -165 -197 16.27% | -193 -190 -1.37% | 0,00 | -169 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -103 -110 5.93% | -165 -195 15.29% | -185 -186 0.69% | 0,00 | -145 |
|
Net income Million TWD | Released Forecast Spread | -103 -110 5.91% | -165 -195 15.28% | -185 -186 0.68% | -164 | -145 |
|
EPS TWD | Released Forecast Spread | -1,33 -1,34 0.75% | -2,02 -2,39 15.48% | -2,26 -2,28 0.88% | -2,01 | -1,78 |
| Announcement Date | 28/03/21 | 28/03/22 | 22/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q3 | 2022 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 110 81,0 35.22% | 121 122 -1.04% | 90,0 | 92,0 | 112 | 136 | |
|
EBIT Million TWD | Released Forecast Spread | -23,6 -56,0 57.94% | -39,4 -37,0 -6.37% | -43,0 | -51,0 | -42,0 | -34,0 | |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -25,4 -56,0 54.56% | -35,2 -37,0 4.84% | -37,0 | -45,0 | -36,0 | -28,0 | |
|
Net income Million TWD | Released Forecast Spread | -25,5 -56,0 54.51% | -44,1 | -35,2 -37,0 4.84% | -37,0 | -45,0 | -36,0 | -28,0 |
|
EPS TWD | Released Forecast Spread | -0,31 -0,68 54.41% | -0,54 | -0,43 -0,45 4.44% | -0,45 | -0,55 | -0,44 | -0,34 |
| Announcement Date | 28/03/22 | 11/11/22 | 22/03/23 | - | - | - | - |
More events
Past sector events for Applied BioCode Corporation
| 09/05/2024 | SEEGENE, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | GUARDANT HEALTH, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:01 | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release |
| 07/05/2024 21:05 | VERACYTE, INC.: Q1 2024 Earnings Release |
| 26/04/2024 | BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release |
| 12/04/2024 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 28/02/2024 21:05 | CAREDX, INC: Q4 2023 Earnings Release |
| 28/02/2024 21:01 | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6598 Stock
- Calendar Applied BioCode Corporation
